229 related articles for article (PubMed ID: 17917783)
1. Cyanotic congenital heart disease (CCHD) with symptomatic erythrocytosis.
Rose SS; Shah AA; Hoover DR; Saidi P
J Gen Intern Med; 2007 Dec; 22(12):1775-7. PubMed ID: 17917783
[TBL] [Abstract][Full Text] [Related]
2. Blood is thicker than water: the management of hyperviscosity in adults with cyanotic heart disease.
DeFilippis AP; Law K; Curtin S; Eckman JR
Cardiol Rev; 2007; 15(1):31-4. PubMed ID: 17172881
[TBL] [Abstract][Full Text] [Related]
3. Iron deficiency in a patient with extreme erythrocytosis due to cyanotic congenital heart disease.
Braun SL; Eicken A; Kaemmerer H
Int J Cardiol; 2007 Mar; 116(2):e74-5. PubMed ID: 17097163
[TBL] [Abstract][Full Text] [Related]
4. Risk of stroke in adults with cyanotic congenital heart disease.
Perloff JK; Marelli AJ; Miner PD
Circulation; 1993 Jun; 87(6):1954-9. PubMed ID: 8504509
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea therapy for management of secondary erythrocytosis in cyanotic congenital heart disease.
Reiss UM; Bensimhon P; Zimmerman SA; Ware RE
Am J Hematol; 2007 Aug; 82(8):740-3. PubMed ID: 17506064
[TBL] [Abstract][Full Text] [Related]
6. Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia.
Horigome H; Hiramatsu Y; Shigeta O; Nagasawa T; Matsui A
J Am Coll Cardiol; 2002 Mar; 39(6):1072-7. PubMed ID: 11897453
[TBL] [Abstract][Full Text] [Related]
7. Cyanotic congenital heart disease (CCHD): focus on hypoxemia, secondary erythrocytosis, and coagulation alterations.
Zabala LM; Guzzetta NA
Paediatr Anaesth; 2015 Oct; 25(10):981-9. PubMed ID: 26184479
[TBL] [Abstract][Full Text] [Related]
8. Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis.
Horigome H; Murakami T; Isobe T; Nagasawa T; Matsui A
Thromb Res; 2003; 112(4):223-7. PubMed ID: 14987915
[TBL] [Abstract][Full Text] [Related]
9. Serum Iron Status of Children with Cyanotic Congenital Heart Disease in Lagos, Nigeria.
Itiola AY; Animasahun BA; Njokanma OF
Sultan Qaboos Univ Med J; 2019 Nov; 19(4):e345-e351. PubMed ID: 31897318
[TBL] [Abstract][Full Text] [Related]
10. Adults with cyanotic congenital heart disease: hematologic management.
Perloff JK; Rosove MH; Child JS; Wright GB
Ann Intern Med; 1988 Sep; 109(5):406-13. PubMed ID: 3044212
[TBL] [Abstract][Full Text] [Related]
11. Management of polycythaemia in adults with cyanotic congenital heart disease.
Thorne SA
Heart; 1998 Apr; 79(4):315-6. PubMed ID: 9616333
[No Abstract] [Full Text] [Related]
12. Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis.
Gordeuk VR; Key NS; Prchal JT
Haematologica; 2019 Apr; 104(4):653-658. PubMed ID: 30872370
[TBL] [Abstract][Full Text] [Related]
13. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis.
Evers D; Kerkhoffs JL; Van Egmond L; Schipperus MR; Wijermans PW
J Clin Apher; 2014 Jun; 29(3):133-8. PubMed ID: 24130064
[TBL] [Abstract][Full Text] [Related]
14. Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease.
Rosove MH; Perloff JK; Hocking WG; Child JS; Canobbio MM; Skorton DJ
Lancet; 1986 Aug; 2(8502):313-5. PubMed ID: 2874330
[TBL] [Abstract][Full Text] [Related]
15. Headache and papilledema in an adult with cyanotic congenital heart disease: the importance of fundoscopic evaluation rather than phlebotomy.
Loomba RS; Leavitt JA; Cetta F
Congenit Heart Dis; 2012; 7(3):E14-7. PubMed ID: 22070674
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentation of a patient with congenital polycythemia.
Hajnzić TF; Vrsalović R; Mataija M
Coll Antropol; 2006 Mar; 30(1):221-3. PubMed ID: 16617601
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic erythroapheresis: Experience in patients with polycythemia vera and secondary erythrocytosis.
Parra Salinas I; Recasens Flores V; Montañés MÁ; García-Erce JA
Med Clin (Barc); 2020 Jan; 154(1):16-19. PubMed ID: 30795904
[TBL] [Abstract][Full Text] [Related]
18. A clinico-hematological study of iron deficiency anemia and its correlation with hyperviscosity symptoms in cyanotic congenital heart disease.
Gaiha M; Sethi HP; Sudha R; Arora R; Acharya NR
Indian Heart J; 1993; 45(1):53-5. PubMed ID: 8365742
[TBL] [Abstract][Full Text] [Related]
19. Hyperviscosity syndrome revisited.
Gangopadhyay D; Roy M; Laha S; Nandi D; Sengupta R; Chattopadhyay A
Ann Pediatr Cardiol; 2022; 15(3):284-290. PubMed ID: 36589657
[TBL] [Abstract][Full Text] [Related]
20. Polycythemia Vera.
Spivak JL
Curr Treat Options Oncol; 2018 Mar; 19(2):12. PubMed ID: 29516275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
